References
- Aillon KL, Xie Y, El-Gendy N, Berkland CJ, Forrest ML. Effects of nanomaterial physicochemical properties on in vivo toxicity. Adv Drug Deliv Rev, 2009;61:457–66.
- Alexis F, Pridgen E, Molnar LK, Farokhzad OC. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm, 2008;5:505.
- Alkilany AM, Murphy CJ. Toxicity and cellular uptake of gold nanoparticles: What we have learned so far? J Nanopart Res, 2010;12:2313–33.
- Avgoustakis K. Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: Preparation, properties and possible applications in drug delivery. Curr Drug Deliv, 2004;1:321–33.
- Avgoustakis K, Beletsi A, Panagi Z, Klepetsanis P, Karydas AG, Ithakissios DS. PLGA-mPEG nanoparticles of cisplatin: In vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. J Controlled Release, 2002;79:123–35.
- Blasi F, Aliberti S, Tarsia P. Clinical applications of azithromycin microspheres in respiratory tract infections. Int J Nanomed, 2007;2:551–9.
- Burger A. The history of penicillin production. J Med Chem, 1971;14:86.
- Butler MS. The role of natural product chemistry in drug discovery†. J Nat Prod, 2004;67:2141.
- Cockerill FR. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: Approved standard: Clinical and Laboratory Standards Institute.
- Dobrovolskaia MA, Mcneil SE. Immunological properties of engineered nanomaterials. Nat Nanotechnol, 2007;2:469–478.
- Duan Y, Zhang Y, Gong T, Zhang Z. Synthesis and characterization of MeO–PEG–PLGA–PEG–OMe copolymers as drug carriers and their degradation behavior in vitro. J Mater Sci, 2007;18:2067–73.
- Farokhzad OC, Langer R. Nanomedicine: Developing smarter therapeutic and diagnostic modalities. Adv Drug Deliv Rev, 2006;58:1456.
- Foster TJ, Geoghegan JA, Ganesh VK, Höök M. Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus. Nat Rev Microbiol, 2014;12:49.
- Gao P, Nie X, Zou M, Shi Y, Cheng G. Recent advances in materials for extended-release antibiotic delivery system. J Antibiot, 2011;64:625–34.
- Gong C. Carrier-free nanoassemblies of a novel oxazolidinone compound FYL-67 display antimicrobial activity on methicillin-resistant Staphylococcus aureus. Nanoscale, 2013;5:275–83.
- Gou M, Men K, Shi H, Xiang M, Zhang J, Song J, Long J, Wan Y, Luo F, Zhao X. Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo. Nanoscale, 2011;3:1558–67.
- Hart CA, Kariuki S. Antimicrobial resistance in developing countries. Bmj Clinical Research, 1998;317:647–50.
- Hillaireau H, Couvreur P. Nanocarriers’ entry into the cell: Relevance to drug delivery. Cell Mol Life Sci, 2009;66:2873–2896.
- Jackson J, Fernandes AW, Nelson W. A naturalistic comparison of amoxicillin/clavulanate extended release versus immediate release in the treatment of acute bacterial sinusitis in adults: A retrospective data analysis. Clin Ther, 2006;28:1462–1471.
- Jacobs MR. Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters. Clin Microbiol Infect, 2001;7:589–596.
- Jeong B, You HB, Lee DS, Kim SW. Biodegradable block copolymers as injectable drug-delivery systems. Nature, 1997;388:860–2.
- Jianxiang Zhang PXM. Host-guest interaction mediated polymeric core-shell assemblies: versatile nanocarriers for drug delivery. Angewandte Chemie, 2009;48:964.
- Khalil NM, Carraro E, Cótica LF, Mainardes RM. Potential of polymeric nanoparticles in AIDS treatment and prevention. Expert Opin Drug Deliv, 2011;8:95.
- Khalil NM, Do Nascimento TC, Casa DM, Dalmolin LF, De Mattos AC, Hoss I, Romano MA, Mainardes RM. Pharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles after oral administration in rats. Colloids Surf B Biointerfaces, 2013;101:353–360.
- Khalil NM, Mainardes RM. Colloidal polymeric nanoparticles and brain drug delivery. Curr Drug Deliv, 2009;6:261–273.
- Kumari A, Yadav SK, Pakade YB, Singh B, Yadav SC. Development of biodegradable nanoparticles for delivery of quercetin. Colloids Surf B Biointerfaces, 2010a;80:184–92.
- Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces, 2010b;75:1–18.
- Li M, Rouaud O, Poncelet D. Microencapsulation by solvent evaporation: State of the art for process engineering approaches. Int J Pharm, 2008;363:26–39.
- Liggins RT, Burt HM. Polyether-polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations. Adv Drug Deliv Rev, 2002;54:191–202.
- Liu S, Maheshwari R, Kiick KL. Polymer-based therapeutics. Macromolecules, 2009;42:3–13.
- Liu X, Li Z, Wang X, Chen Y, Wu F, Men K, Xu T, Luo Y, Yang L. Novel antimicrobial peptide–modified azithromycin-loaded liposomes against methicillin-resistant Staphylococcus aureus. International Journal of Nanomedicine, 2016;11:6781.
- Lowy FD. Staphylococcus aureus infections. N Engl J Med, 1999;339:2026–2027.
- Merisko-Liversidge E, Liversidge GG, Cooper ER. Nanosizing: A formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci, 2003;18:113–20.
- Morlock M, Kissel T, Li YX, Koll H, Winter G. Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: Protein stabilization and in-vitro release properties. J Controlled Release, 1998;56:105.
- Nava-Arzaluz MG, Piñón-Segundo E, Ganem-Rondero A, Lechuga-Ballesteros D. Single emulsion-solvent evaporation technique and modifications for the preparation of pharmaceutical polymeric nanoparticles. Recent Patents on Drug Delivery & Formulation, 2012;6:209–223.
- O’donnell PB, Mcginity JW. Preparation of microspheres by the solvent evaporation technique. Adv Drug Deliv Rev, 1997;28:25.
- Pearson R, Steigbigel R, Davis H, Chapman S. Method of reliable determination of minimal lethal antibiotic concentrations. Antimicrob Agent Chemother, 1980;18:699–708.
- Peng F, Wan F, Xiong L, Peng C, Dai M, Chen J. In vitro and in vivo antibacterial activity of pogostone. Chinese Med J, 2014;127:4001–4005.
- Pfaller MA, Wenzel RP. Vancomycin-resistant enterococcus faecium bacteremia: Risk factors for infection. Clin Infect Dis, 1995;20:1126.
- Riehemann K, Schneider SW, Luger TA, Godin B, Ferrari M, Fuchs H. Nanomedicine–challenge and perspectives. Angewandte Chemie Int Ed, 2009;48:872.
- Roberts JA, Lipman J, Blot S, Rello J. Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients? Curr Opin Crit Care, 2008;14:390–6.
- Roberts JA, Paratz J, Paratz E, Krueger WA, Lipman J. Continuous infusion of beta-lactam antibiotics in severe infections: A review of its role. Int J Antimicrob Agents, 2007;30:11–18.
- Rosca ID, Watari F, Uo M. Microparticle formation and its mechanism in single and double emulsion solvent evaporation. J Control Release, 2004;99:271–80.
- Russo L, Zaccaria S, Autiello MA, Borzacchiello A. 2013. Hydrogels for biomedical applications.
- Seil JT, Webster TJ. Antimicrobial applications of nanotechnology: Methods and literature. Int J Nanomed, 2012;7:2767–81.
- Shu YZ. Recent natural products based drug development: A pharmaceutical industry perspective. J Nat Prod, 1998;61:1053–71.
- Swann J. Miracle cure: the story of penicillin and the golden age of antibiotics. Br J History Sci, 1992;25:376–377.
- Tong SY, Davis JS, Eichenberger E, Holland TL, & Fowler VG. Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev, 2015;28:603–61.
- Wikler MA. 2002. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. Clinical & Laboratory Standards Institute. M7-A7.
- Xian Yang XZ, Shui-Ping Y, Wei-Qi L. Evaluation of the antibacterial activity of patchouli oil. Iran J Pharm Res, 2013;12:307.
- Zhang K, Tang X, Zhang J, Lu W, Lin X, Zhang Y, Tian B, Yang H, He H. PEG-PLGA copolymers: Their structure and structure-influenced drug delivery applications. J Controlled Release, 2014;183:77–86.